1. Define the decision before the data room.
Write down what the proposed investment must accomplish. A buyer seeking product protection, an investor assessing a business, and a funder evaluating an enforcement campaign need different work. Specify the patents, jurisdictions, counterparties, budget, deadline, and intended use of the findings.
Separate an initial screen from deeper diligence. A screen can prioritize assets and expose missing information. It should not quietly become a validity opinion, infringement analysis, valuation, or freedom-to-operate review. List each included workstream, its deliverable, and the questions expressly left open.
Agree who can rely on the work and who will receive it. Coordinate sensitive document access with counsel before distributing a data room to multiple prospective participants.
2. Build an evidence register.
Use one row per asset, with family relationships recorded separately. Every material field should have a source, the date checked, an owner for follow-up, and a status such as verified, pending, or disputed. Preserve the distinction between a seller’s representation and an independently checked record.
Tick the boxes during your review, or print this guide. Selections are not submitted. A checked box means the item has been addressed in your process, not that a legal conclusion has been established.
3. Confirm the rights behind the record.
An assignment search is a starting point. USPTO recordation does not determine whether an assignment is valid or what ownership it conveys. Read the underlying documents and reconcile gaps, names, dates, and affected assets. USPTO ownership and assignment guidance.
Ask whether a missing signature, an earlier license, a co-owner, or a security interest could change what the buyer receives. Have counsel identify the consequence and any required cure rather than treating every discrepancy as an administrative cleanup.
Check current status and maintenance history for each priority asset. U.S. utility patents generally require maintenance payments; design and plant patents do not. Calculate remaining term separately and investigate any lapse or reinstatement issue. USPTO maintenance guidance.
4. Connect claims to the business case.
Start with the claims selected for review, not only the abstract, title, or a technology label. For each priority claim, identify the relevant product or process, the evidence available, and the features that need further investigation. Distinguish an observed fact from an inference and record alternative explanations.
A patent provides exclusionary rights; ownership alone does not establish permission to commercialize a product. If the transaction depends on operating freedom, scope that question separately. USPTO explanation of patent rights.
Review the prosecution record, known prior art, earlier disputes, and practical obstacles to collecting evidence. A favorable automated score cannot resolve those questions. Avoid building an economic model around assumed infringement or an untested royalty rate.
5. Turn findings into decisions.
The final output should explain what changes the proposed transaction, what can be investigated next, and what remains uncertain. Use a decision register rather than a single portfolio grade.
| Finding | Decision question | Possible next work |
|---|---|---|
| Unresolved title link | Can the seller convey the needed rights? | Review the missing instrument and any proposed cure before relying on the asset. |
| Thin product evidence | Does the campaign thesis warrant further expense? | Scope technical investigation before committing to an enforcement model. |
| Limited remaining term | Does the timing fit the commercial plan? | Rework the timeline and sensitivity analysis with counsel. |
| Existing license | Which opportunities remain available? | Read the grant, coverage, transfer terms, and relevant counterparties. |
Assign each unresolved issue an owner and decision date. The investment team should understand both the favorable evidence and the conditions on which the recommendation depends. A defined stopping point can be as useful as a recommendation to proceed.
For an acquisition, connect material findings to the proposed asset schedule, closing conditions, reserved rights, and post-closing responsibilities. For a funding review, identify the assumptions counsel has assessed and the underwriting questions that remain with the funder. Record who must approve a change in strategy or budget. In either setting, make it possible to trace a conclusion back to its evidence and identify when a changed fact should reopen the decision.